A Phase 1, Double-Blind, Randomised, Placebo-Controlled, Parallel Group, Oral Single-Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04457845 In Healthy Volunteers

Trial Profile

A Phase 1, Double-Blind, Randomised, Placebo-Controlled, Parallel Group, Oral Single-Dose Trial To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04457845 In Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2011

At a glance

  • Drugs PF 4457845 (Primary)
  • Indications Pain
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 27 Dec 2011 New trial record
    • 02 Nov 2011 Results published in the British Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top